What bacteria is associated with a sweet, banana-like pus smell?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pseudomonas aeruginosa is Associated with a Sweet, Grape-like or Fruity Odor

Pseudomonas aeruginosa is distinctively associated with a sweet, grape-like or fruity odor that has been described as similar to grapes, fruit, or occasionally as having a sweet smell.

Characteristic Odor of Pseudomonas aeruginosa

Pseudomonas aeruginosa produces a characteristic sweet smell that is often described as grape-like or fruity. This distinctive odor is an important clinical identifier that can help in the preliminary identification of this pathogen in clinical settings.

The smell is primarily due to:

  • Production of volatile compounds including hydrogen cyanide (HCN) gas, which can be detected at significant levels (>100 ppb) in the headspace above Pseudomonas aeruginosa cultures 1
  • Other volatile metabolites that contribute to its characteristic sweet, fruity odor

Clinical Relevance of Pseudomonas Odor

The distinctive smell of Pseudomonas aeruginosa has important clinical implications:

  • Can serve as an early indicator of Pseudomonas infection before laboratory confirmation
  • Particularly relevant in settings where rapid identification is crucial, such as:
    • Burn units
    • Intensive care settings
    • Cystic fibrosis clinics
    • Wound care centers

Common Clinical Presentations with Characteristic Odor

Pseudomonas aeruginosa is commonly encountered in:

  • Chronic wounds and serious burns where it frequently colonizes 2
  • Respiratory infections, particularly in cystic fibrosis patients
  • Ecthyma gangrenosum, a characteristic skin lesion that marks immunosuppression or reveals septicemia 2
  • Folliculitis favored by water sports 2
  • Healthcare-associated infections, as P. aeruginosa is a principal cause worldwide 3

Diagnostic Value

The characteristic odor can provide valuable diagnostic clues:

  • In a study using Selected Ion Flow Tube Mass Spectrometry (SIFT-MS), hydrogen cyanide gas levels greater than 100 ppb were found to be a sensitive (68%) and highly specific (100%) biomarker of P. aeruginosa 1
  • This distinctive smell can alert clinicians to the possibility of Pseudomonas infection before laboratory confirmation

Treatment Considerations

When Pseudomonas aeruginosa is suspected based on clinical presentation and characteristic odor:

  • Consider risk factors for P. aeruginosa including:

    • Recent hospitalization
    • Frequent or recent administration of antibiotics
    • Severe underlying disease
    • Immunosuppression 4
  • Initial empiric therapy should consider local resistance patterns as P. aeruginosa has high levels of intrinsic and acquired antimicrobial resistance 3

  • Be aware that P. aeruginosa can form biofilms that contribute to persistent infections and treatment resistance 5

Clinical Pitfalls and Caveats

  • While the smell is characteristic, laboratory confirmation is still necessary for definitive diagnosis
  • Other bacteria can also produce distinctive odors, so the smell alone is not diagnostic
  • Pseudomonas aeruginosa infections can be polymicrobial, especially in chronic wounds and diabetic foot infections 4
  • The organism has multiple virulence factors and resistance mechanisms that make treatment challenging 3, 6

The characteristic sweet, grape-like or fruity odor of Pseudomonas aeruginosa provides a valuable clinical clue that can help guide early empiric therapy while awaiting definitive laboratory confirmation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.